These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5712175)

  • 1. [Study of amplivix in gout patients and nongouty arthrosic hyperuricemics].
    Doumerg C
    Rhumatologie; 1968 Oct; 20(8):285-8. PubMed ID: 5712175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with benziodarone therapy in gout and hyperuricemic syndrome].
    Jorda V; Vykydal M; Pegrimová E; Bouvenot G
    Beitr Rheumatol; 1972; 18():96-9. PubMed ID: 4649127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 5. [The hypouricemic effect of benziodarone].
    Gospodinoff L; Salvini S
    Clin Ter; 1969 Oct; 51(2):153-8. PubMed ID: 5365825
    [No Abstract]   [Full Text] [Related]  

  • 6. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R; Hueber EF
    Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract]   [Full Text] [Related]  

  • 7. [Benziodarone (Amplivix) in the treatment of hyperuricemia].
    Antila V; Elsilä M
    Duodecim; 1969; 85(7):428-30. PubMed ID: 5799173
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
    Barcelo P; Santamaria A
    Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term therapy with benzbromarone in uric arthritis].
    Bröll H; Sochor H; Tausch G; Eberl R
    Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
    [No Abstract]   [Full Text] [Related]  

  • 11. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 13. A new potent hypouricemic drug. A clinical trial of the drug in a group of gouty patients.
    Serry MM
    J Egypt Med Assoc; 1979; 62(1-2):255-61. PubMed ID: 400475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benziodarone in the treatment of primary hyperuricemias].
    Bianco G; Marcolongo R; Carcassi A
    Minerva Med; 1968 Dec; 59(99):5470-81. PubMed ID: 5718835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Benziodarone in hyperuricemia due to renal insufficiency].
    Boine L
    Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A; Giudicelli CP
    Sem Hop Ther; 1976; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia].
    van Bogaert P
    J Belge Rhumatol Med Phys; 1969; 24(6):295-315. PubMed ID: 5403086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.